Yang M H, Li L, Kuo Y F, Hung Y S, Yu L C, Hung C S, Tsai S J L, Lin K S, Chu D C
Taipei Blood Center, Taiwan Blood Services Foundation, Taiwan.
Transfus Med. 2011 Oct;21(5):318-24. doi: 10.1111/j.1365-3148.2011.01084.x. Epub 2011 Jun 26.
AIMS/OBJECTIVES: The purpose of this study was to explore the molecular basis of the K0 phenotype of a Taiwanese blood donor found to have anti-Ku alloantibodies.
With respect to Kell blood group antigens, almost all Taiwanese have the (K-, k+) phenotype.
Alloantibody identification and KEL antigen typing were performed. Enzymatic function assays were carried out to detect the Kell glycoprotein on RBCs. The KEL genes were sequenced to detect genetic variation. To determine the origin of this novel allele, family studies were conducted.
The alloantibody was identified as anti-Ku. The donor was typed K0 . The KEL gene-sequencing data revealed that this K0 donor is a compound heterozygote with two different null alleles. He bears a novel 730delG mutation in one allele. Family studies suggested that the donor inherited the 730delG mutation from his father. The endothelin-converting activity assay indicated that his RBCs had no functional Kell glycoprotein. Other family members who had only one null allele with the 730delG mutation had the phenotype (K-, k+).
For blood transfusion safety, it is important to establish an effective screening algorithm to identify rare phenotypes, such as the K0 phenotype, and to establish a database of rare blood groups.
本研究旨在探究一名台湾献血者被发现具有抗-Ku同种抗体的K0表型的分子基础。
关于凯尔血型抗原,几乎所有台湾人都具有(K-,k+)表型。
进行了同种抗体鉴定和KEL抗原分型。开展酶功能测定以检测红细胞上的凯尔糖蛋白。对KEL基因进行测序以检测基因变异。为确定这个新等位基因的起源,进行了家系研究。
该同种抗体被鉴定为抗-Ku。该献血者被分型为K0。KEL基因测序数据显示,这位K0献血者是具有两个不同无效等位基因的复合杂合子。他的一个等位基因存在一个新的730delG突变。家系研究表明,该献血者从其父亲那里继承了730delG突变。内皮素转化活性测定表明,他的红细胞没有功能性凯尔糖蛋白。其他仅具有一个带有730delG突变的无效等位基因的家庭成员具有(K-,k+)表型。
为确保输血安全,建立有效的筛查算法以识别罕见表型(如K0表型)并建立稀有血型数据库非常重要。